All good @webral,if you have a program that shows depth all day in I read, then you will find tg at depth it was only momentarily.My early comments were based on at depth, in fact at that time 800plus million were on the but depth at .002 momentarily.
Can I ask.webral were you able to buy at .002. If you paid .0025, can I ask how you go about achieving the decimal as I either have to wait, or pay .003 currently.
I agree though, that this is kind of a different company than it was last week, and my heart goes out to the long term holders that have had to go through this.
drifta
- Forums
- ASX - By Stock
- DLM
- Ann: Results of Phase 2 Clinical Trial
Ann: Results of Phase 2 Clinical Trial, page-145
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online